Codeine Phosphate/Guaifenesin ER Tablet 30 mg/600 mg Steady State Clinical Study
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The objectives of this pivotal study are:
1. to evaluate bioavailability of an extended-release and immediate release Codeine
Phosphate/Guaifenesin tablet at steady state following multiple oral administration
2. to assess the safety and tolerability of this Codeine Phosphate/Guaifenesin extended
release formulation.
Phase:
Phase 1
Details
Lead Sponsor:
Nexgen Pharma, Inc
Collaborator:
Pharmaceutical Research Unit, Jordan
Treatments:
Chlorpheniramine, phenylpropanolamine drug combination Codeine Guaifenesin Phenylpropanolamine